Cargando…
The Prevention Role of Theaflavin-3,3′-digallate in Angiotensin II Induced Pathological Cardiac Hypertrophy via CaN-NFAT Signal Pathway
Theaflavin-3,3′-digallate (TF3) is a representative theaflavin of black tea and is remarkable for the anti-coronary heart disease effect. As an adaptive response to heart failure, pathological cardiac hypertrophy (PCH) has attracted great interest. In this study, the PCH cell model was established w...
Autores principales: | Zhou, Hui, Xia, Chen, Yang, Yaqing, Warusawitharana, Hasitha Kalhari, Liu, Xiaohui, Tu, Youying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003418/ https://www.ncbi.nlm.nih.gov/pubmed/35406003 http://dx.doi.org/10.3390/nu14071391 |
Ejemplares similares
-
Antibacterial and Sporicidal Activity Evaluation of Theaflavin-3,3′-digallate
por: Yussof, Ayuni, et al.
Publicado: (2022) -
Theaflavin-3,3′-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells
por: Pan, Haibo, et al.
Publicado: (2018) -
Inhibition of α-hemolysin activity of Staphylococcus aureus by theaflavin 3,3’-digallate
por: Goc, Anna, et al.
Publicado: (2023) -
Theaflavin-3,3′-Digallate Suppresses Human Ovarian Carcinoma OVCAR-3 Cells by Regulating the Checkpoint Kinase 2 and p27 kip1 Pathways
por: Gao, Ying, et al.
Publicado: (2019) -
Simultaneous Tests of Theaflavin-3,3′-digallate as an Anti-Diabetic Drug in Human Hepatoma G2 Cells and Zebrafish (Danio rerio)
por: Zhou, Hui, et al.
Publicado: (2021)